Introduction {#s1}
============

During mammalian fertilization, maternal and paternal chromatids are combined to form a fully totipotent embryo. In oocytes, gene expression is maintained in a silent state during maturation [@pone.0100205-Worrad1], [@pone.0100205-Latham1]. When oocytes are fertilized by sperm, the zygotes undergo reprogramming and genome activation, followed by replacement of maternal transcripts with embryonic transcripts that regulate embryonic development [@pone.0100205-Kanka1], [@pone.0100205-Hamatani1], [@pone.0100205-Wang1].

The timing of genome activation is different among species. Embryonic genome activation (EGA) in mice occurs at the 2-cell stage [@pone.0100205-Schultz1], whereas porcine and bovine embryos initiate genome transcription at the 4-cell and 8-cell stage, respectively [@pone.0100205-Bjerregaard1], [@pone.0100205-Barnes1]. Although the mechanisms regulating EGA are still not clear, changes in chromatin structure in the early embryo may play an important role. Chromatin compaction affects the accessibility of proteins that regulate gene expression, such as transcription factors and RNA polymerases [@pone.0100205-Mason1], [@pone.0100205-Dillon1]. The major events involved in this process include changes in DNA methylation and histone acetylation or methylation [@pone.0100205-Kouzarides1], [@pone.0100205-Li1]. In particular, methylation of histones at specific residues is an important epigenetic modification, playing an essential role in both activating and repressing transcription during embryonic development, depending on which lysine residues are methylated [@pone.0100205-Zhang1], [@pone.0100205-Martin1], [@pone.0100205-Ng1], [@pone.0100205-Surani1], [@pone.0100205-Santos1]. For example, histone H3 tri-methylated at lysine 4 (H3K4me3) is known to be associated with gene activation [@pone.0100205-Schneider1], [@pone.0100205-Schbeler1], [@pone.0100205-Miao1], [@pone.0100205-Zhao1], whereas histone H3 di-methylated and tri-methylated at lysine 9 (H3K9me2 and -me3) and histone H3 tri-methylated at lysine 27 (H3K27me3) are associated with gene silencing [@pone.0100205-Sims1], [@pone.0100205-Pan1].

Histone H3 methylation at lysine 36 (H3K36) is another important post-translational modification that is associated with transcription elongation. In yeast, H3K36 methylation which is mediated by Set2, is associated with transcribed genes and is usually referred to as an activating histone mark [@pone.0100205-Morris1]. Di-methylation and tri-methylation of H3K36 (H3K36me2 and -me3) are generally associated with actively transcribed genes, whereas only H3K36me3 is positively correlated with transcription rates [@pone.0100205-Pokholok1], [@pone.0100205-Rao1]. H3K36me3 enrichment in the coding region of transcribed genes is a mark of the actively transcribed chromatin associated with transcription elongation [@pone.0100205-Barski1]. During transcription elongation, the chromodomain of Eaf3, a subunit of the Rpd3S histone deacetylase complex, recognizes Set2-mediated H3K36 methylation; the resulting complex is then recruited in the wake of the transcribing RNA polymerase II [@pone.0100205-Joshi1], [@pone.0100205-Keogh1]. Accordingly, H3K36 methylation is also a mark for histone deacetylation [@pone.0100205-Lee1]. Without Set2 or Rpd3S, acetylated histones accumulate on open reading frames (ORFs), which can lead to transcription initiation from cryptic promoters within ORFs [@pone.0100205-Carrozza1], [@pone.0100205-Li2]. Thus, Set2 regulates the methylation of histone H3K36, suppressing the incorporation of acetylation and thereby decreasing the initiation of spurious cryptic transcription from within ORFs; this pathway can maintain the accuracy of transcription by RNA polymerase II [@pone.0100205-Venkatesh1].

Although considerable research on H3K36 methylation has been reported in yeast, there is limited information about H3K36 methylation in mammals. To date, H3K36 methylations in porcine oocytes and preimplantation embryos have not been reported. In the current study, we investigated the changes in H3K36 methylation status in porcine oocytes, and parthenogenetic and in vitro-fertilized (IVF) embryos to determine whether this epigenetic modification is related to genome activation. As in somatic cell nuclear transfer (SCNT) embryos, abnormal epigenetic modification is known to be a major reason for the low efficiency; we also investigated the H3K36 methylation status in SCNT embryos to determine whether these embryos have abnormalities in this epigenetic modification compared with IVF embryos.

Materials and Methods {#s2}
=====================

Chemicals and Ethics {#s2a}
--------------------

Unless otherwise noted, chemicals were purchased from Sigma-Aldrich Chemical Company (St. Louis, MO, USA). All animal care and use procedures were approved by the Institutional Animal Care and Use Committee of Chungnam National University.

Porcine Oocyte Collection and in vitro Maturation {#s2b}
-------------------------------------------------

Porcine ovaries were obtained from a local slaughterhouse (NH Livestock Cooperation Association, Nonsan City, Chungnam Province, Korea) where we had acquired permission to use porcine ovaries, and transported to the laboratory within 2 h in phosphate-buffered saline (PBS) solution supplemented with 100 IU/ml penicillin and 50 µg/ml streptomycin at 30 to 35°C. Cumulus-oocyte complexes (COCs) were obtained from follicles (2--6 mm in diameter) using a 10-ml syringe fixed with an 18-gauge needle. The COCs were washed three times in TL-HEPES containing 0.1% (w/v) polyvinyl alcohol (PVA). The oocytes were then cultured in maturation medium (500 µl per well, see below for details) in 4-well plates (Nunc, Roskilde, Denmark) and incubated for 42 to 44 h at 38.5°C in humidified air containing 5% CO~2~. After 22 h of in vitro maturation, the oocytes were washed three times and transferred to 500 µl of maturation medium without hormones for an additional 20 to 22 h of culture. The maturation medium consisted of TCM-199 (M-4530, Sigma) supplemented with 10% (v/v) porcine follicular fluid, 3.05 mM D-glucose, 0.91 mM sodium pyruvate, 0.57 mM L-cysteine, 0.5 µg/ml LH (L-5269, Sigma), 0.5 µg/ml FSH (F-2293, Sigma), 10 ng/ml epidermal growth factor (E-4127, Sigma), 75 µg/ml penicillin, 50 µg/ml streptomycin, and 0.05% (v/v) MEM vitamins (M-6895, Sigma). Following in vitro maturation, the COCs were transferred to 0.3% hyaluronidase in TL-HEPES-PVA and pipetted repeatedly for 2 min to denude the oocytes of cumulus cells.

Preparation of Porcine Fetal Fibroblasts {#s2c}
----------------------------------------

In this manuscript, all animal procedures were approved by the Institutional Animal Care and Use Committee of Chungnam National University. The porcine fetal fibroblasts used in this study were isolated from Korean native pig fetuses at day 35 of gestation. The head and internal tissues were removed using fine scissors, and soft tissues such as liver and intestine were discarded. The remaining tissue was cut into small pieces with fine scissors, treated with 0.05% trypsin and 0.5 mM EDTA (15050-065, Gibco), and shaken for 10 min at 38.5°C. The resulting suspension was centrifuged at 500 rpm for 10 min, and the pellet (containing porcine fetal fibroblasts) was washed three times in DMEM. The cells were resuspended in DMEM containing 75 µg/ml penicillin G, 50 µg/ml streptomycin, 5% (v/v) fetal bovine serum (FBS; 16000-044, Gibco) and 5% (v/v) newborn calf serum (NCS; 26010-074, Gibco), and cultured at 38.5°C. Fetal fibroblasts from passage 5 were used for experiments.

Parthenogenetic Activation {#s2d}
--------------------------

After maturation, cumulus-free oocytes were transferred to activation solution (0.3 M mannitol, 1.0 mM CaCl~2~·H~2~O, 0.1 mM MgCl~2~·6H~2~O, and 0.5 mM HEPES) and activated with one DC pulse of 1.1 kV/cm for 30 µs using a BTX Electro-Cell Manipulator 2001 (BTX, San Diego, CA, USA). Activated embryos were cultured in Porcine Zygote Medium (PZM-3) supplemented with 0.3% bovine serum albumen (BSA) at 38.5°C in humidified air containing 5% CO~2~.

*In vitro* Fertilization {#s2e}
------------------------

In vitro fertilization of oocytes were carried out as described previously by Li *et al*. [@pone.0100205-Li3] After maturation, cumulus-free oocytes with first polar body extruded were washed three times with fertilization medium, a modified Tris-buffered medium (mTBM) containing of 113 mM NaCl, 3 mM KCl, 7.5 mM CaCl~2~·2H~2~O, 5 mM sodium pyruvate, 11 mM glucose, 20 mM Tris, 1 mM caffeine, 0.57 mM L-cysteine, and 0.1% wt/vol BSA. 10 ml fresh semen was transferred into a 15-ml tube and centrifuged at 700×g for 3 min. The pellet was then resuspended and washed once with 1 ml mTCM-199 medium consisting of TCM-199 medium supplemented with 26.2 mM NaHCO~3~, 3.05 mM glucose, 0.91 mM Na-pyruvate, 2.92 mM, Ca-lactate·5H~2~O, 75 mg/l kanamycin, and 10% (vol/vol) FBS (16000-044, Gibco) by centrifugation at 700×g for 3 min; washed twice in 1 ml mTBM at 700×g for 3 min respectively. After the last wash, the sperm pellet was resuspended in mTBM medium and the sperm concentration was adjusted to 1×10^6^ sperm/ml. Approximately 15 to 20 oocytes were transferred into 60 µl droplets of fertilization medium covered with mineral oil at 38.5°C in 5% CO~2~ air for 30 min, to which 10 µl diluted sperm was then added. Oocytes were coincubated with sperm for 6 h at 38.5°C in 5% CO~2~ air, then removed the attached sperm by washing in PZM-3. Thereafter, 10 to 15 zygotes were cultured in 40 µl of in vitro culture medium PZM-3 supplemented with 0.3% BSA, and maintained in a 5% CO~2~ atmosphere at 38.5°C.

Nuclear Transfer {#s2f}
----------------

Nuclear transfer, fusion, and activation were carried out as previously described by Diao *et al*. [@pone.0100205-Diao1]. Cumulus-free oocytes in PZM-3 medium containing 7.5 µg/ml cytochalasin B at 38°C were enucleated by aspirating the first polar body and adjacent cytoplasm with a fine glass pipette. A single donor cell was placed in the perivitelline space of the enucleated each oocyte. SCNT embryos were simultaneously fused and activated with two DC pulses of 1.1 kV/cm for 30-µs each pulse using a BTX Electro-Cell Manipulator 2001 in 0.3 M mannitol medium containing 1.0 mM CaCl~2~·H~2~O, 0.1 mM MgCl~2~·6H~2~O, and 0.5 mM HEPES. Then 10 to 15 embryos were cultured in 40 µl of PZM-3 medium supplemented with 0.3% BSA and maintained in a 5% CO~2~ atmosphere at 38.5°C.

Flavopiridol Treatment and Transcript Labeling {#s2g}
----------------------------------------------

Fetal fibroblasts at passage 5 were seeded onto coverslips in the wells of 6-well dishes containing 3 ml DMEM (supplemented with 10% FBS) per well and grown to 90% confluence for using in experiments. Cells were treated with 200 nM flavopiridol (F3055, Sigma) in DMEM (containing 10% FBS) for 30 min, followed by combined treatment with 200 nM flavopiridol and 2.5 mM 5-fluorouridine (F5130, Sigma) in DMEM (containing 10% FBS) for an additional 30 min. After treatment, the cells were washed briefly in PBS three times and fixed by incubating for 5 min in 2% paraformaldehyde (PFA; 18814, Polysciences, Inc. PA, USA) in PBS. The cells were then transferred to PBS containing 2% PFA and 1% Triton X-100 (X100, Sigma) for 10 min to fix and permeabilize. The cells were further permeabilized in PBS-PVA containing 0.5% Triton X-100 and 100 mM glycine for 40 min, and blocked for 30 min at room temperature in 3% BSA and 0.3% Triton X-100 in PBS. After washing in PBG \[(PBS containing 0.5% BSA and 0.1% gelatin from cold water fish skin (G7041, Sigma)\] for 10 min, the cells were incubated in PBG containing 0.3% Triton X-100 and primary antibodies (1∶100 dilution) against 5-bromo-deoxyuridine (BrdU; B2531, Sigma), H3K36me1 (mono-methyl K36; ab9048, Abcam, Cambridge, UK), H3K36me2 (di-methyl K36; ab9049, Abcam, Cambridge, UK) or H3K36me3 (tri-methyl K36; 9763, Cell Signaling, MA, USA) at 4°C overnight. Cells were then washed in PBG for 10 min and incubated with fluorescein isothiocyanate (FITC)-conjugated bovine anti-rabbit (1∶100 dilution; sc-2365, Santa Cruz Biotechnology, CA, USA) or Texas Red (TR)-conjugated goat anti-mouse (1∶100 dilution; sc-2781, Santa Cruz Biotechnology, CA, USA) secondary antibodies in the dark at room temperature for 1 h. Finally, cells were washed twice with PBG (10 min each) and slide-mounted and stained using mounting medium containing the DNA-binding fluorescent dye, diamidino-2-phenylindol (DAPI; H-1200, Vector Laboratories, Inc. Burlingame, CA). Fetal fibroblasts were observed and imaged using a Zeiss laser-scanning confocal microscope (LSM5 Live, Carl Zeiss, Germany) equipped with ×63 objectives and running Zeiss LSM Image Browser software (Zeiss LSM5 Live Release ver. 4.2. SP1 Image Browser software, Carl Zeiss, Germany).

Immunocytochemistry and Quantification Analysis {#s2h}
-----------------------------------------------

Oocytes and embryos were washed in PBS-PVA (containing 0.1% PVA) for 10 min and fixed in 2% PFA in PBS-PVA for 5 min, followed by combined fixation and permeabilization in PBS-PVA containing 2% PFA and 1% Triton X-100 for 10 min. Oocytes and embryos were then sequentially permeabilized in PBS-PVA containing 0.5% Triton X-100 and 100 mM glycine (G7126, Sigma) for 40 min and blocked in 3% BSA and 0.3% Triton x-100 in PBS for 30 min at room temperature. After washing in PBG for 10 min, oocytes and embryos were incubated in PBG containing 0.3% Triton X-100 and primary antibodies (1∶100 dilution) against H3K36me1, H3K36me2, or H3K36me3 at 4°C overnight. Oocytes and embryos were then washed in PBG for 10 min and incubated with secondary antibodies (1∶100 dilution) in the dark at room temperature for 1 h. Finally, oocytes and embryos were washed twice with PBG (10 min each) and slide-mounted and stained using DAPI-containing mounting medium. Oocytes and embryos were observed and imaged using a Zeiss laser-scanning confocal microscope equipped with ×63 objectives and running Zeiss LSM Image Browser software. Quantification of global H3K36 mono-, di- and tri-methylation of nuclei or cytoplasmic areas was performed using Image J software (National Institutes of Health, Bethesda, MD, USA). The border around nuclei was manually delineated according to DNA staining. In addition, at least two different cytoplasmic areas were delineated for normalization to background. The average pixel intensity of the nuclear areas were calculated by Image J, then normalized by dividing by the average pixel intensity of the background areas.

Statistical Analysis {#s2i}
--------------------

All experiments were replicated at least three times. Statistical analysis was carried out using statistical product and service solutions (SPSS) 17.0 software (Inc. 233 South Wacker Drive, 11th Floor, Chicago). Global H3K36 mono-, di- and tri-methylation were compared by one way analysis of variance (ANOVA). Bars represent least-squares showed the standard error in each group. P-values \<0.05 were considered statistically significant.

Results {#s3}
=======

H3K36 Methylation Status and Association with Transcriptional Activity in Porcine Fetal Fibroblasts {#s3a}
---------------------------------------------------------------------------------------------------

It has been reported that H3K36 methylation is associated with transcription in yeast [@pone.0100205-Pokholok1]. Accordingly, to determine whether H3K36 methylation is related to transcription in mammals, we investigated H3K36 methylation status in porcine fetal fibroblasts using H3K36 methylation status-specific antibodies and employed 5-fluorouridine (FU), a cell-permeable, modified RNA precursor, to label active transcription sites. The cells were incubated with 2.5 mM FU in culture medium for 30 min to allow incorporation of FU into nascent RNAs. Cells were then washed briefly with PBS, fixed, and analyzed immunohistochemically using an antibody specific for 5-bromo-deoxyuridine (BrdU) to detect FU labeling, and antibodies against H3K36me1, -me2 or -me3, to detect mono-, di- and tri-methylated H3K36, respectively. As shown in [Figure 1](#pone-0100205-g001){ref-type="fig"}, all three types of methylations were observed in interphase cells. H3K36me1 and H3K36me2 labeling was evenly distributed throughout the nucleoplasm, but not in the nucleolus, whereas H3K36me3 exhibited a dotted staining pattern in the nucleoplasm. FU labeling corresponding to nascent transcription site was distributed as dotted patten throughout the nucleus and nucleolus. To analyze the association between H3K36 methylation and nascent RNA synthesis, we assayed one transcriptionally active site (indicated by thick arrow) in each methylation group indicated by a dot where nascent FU-labeled RNA had accumulated. In both H3K36me1 and H3K36me2 groups, transcription sites were not colocalized with methylation sites, indicating that these two types of histone modifications are not marks of transcriptional activity. In contrast, staining for H3K36me3 always exhibited a very clear colocalization with FU-labeled sites, suggesting that this modification may be associated with transcriptional activity. To analyze the overall overlap between FU and H3K36 methylation, we chose 30 dots with strong FU labeling in the nucleoplasm for each methylation group (H3K36me1, -me2 and -me3). We found that 80% of the FU labeling dots were well colocalized with H3K36me3, while only 13.3% and 6.7% of the FU labeling dots overlap with H3K36me1 and -me2, respectively ([Fig. 1B](#pone-0100205-g001){ref-type="fig"}).

![H3K36 methylation status and association with transcriptional activity in porcine fetal fibroblasts.\
(A) Cells were cultured in medium containing 2.5 mM FU for 30 min, fixed, and immunostained with antibodies against FU and H3K36me1, -me2 or -me3. Primary antibodies were detected with FITC-conjugated (green) and TR-conjugated (red) secondary antibodies. DNA was stained with DAPI (blue). Enlargements (bottom insets) were the area pointed by thick arrows in merge insets showing transcriptional active sites (labeled with FU), H3K36 methylations and their overlap. The asterisk indicates the nucleolus. (B) The overall overlap rates between H3K36 methylations and transcriptional active sites were analyzed using total 30 dots indicated by the thin and thick arrows in (A).](pone.0100205.g001){#pone-0100205-g001}

Effects of Flavopiridol on H3K36 Methylation and Inactivation of Transcription in Porcine Fetal Fibroblasts {#s3b}
-----------------------------------------------------------------------------------------------------------

Flavopiridol is a cyclin-dependent kinase 9 (CDK9) inhibitor, which inhibits transcription by RNA polymerase II in vitro and in vivo by blocking the transition to productive elongation [@pone.0100205-Chao1], [@pone.0100205-Chao2]. In preliminary experiments, we confirmed that 200 nM flavopiridol inhibited global transcription more efficiently than 100 nM in porcine fetal fibroblast cells; the transcription could be completely abrogated. Thus, to further investigate the association of H3K36 methylations with transcription, we treated fetal fibroblasts with 200 nM flavopiridol to inhibit transcriptional activity. Cells were treated with flavopiridol and FU and subsequently immunostained with antibodies against BrdU (detecting FU labeling) and H3K36me1, -me2, or -me3. The untreated cells were shown in [Figure 1](#pone-0100205-g001){ref-type="fig"}. As shown in [Figure 2](#pone-0100205-g002){ref-type="fig"}, after treatment with flavopiridol, transcriptional signals were undetectable. H3K36me3 staining was also absent in these cells, whereas H3K36me1 and -me2 signals still remained intact.

![Effect of flavopiridol treatment on H3K36 methylation status in porcine fetal fibroblasts.\
Cells were treated with 200(FP) for 30 min, followed by combined treatment with 200 nM flavopiridol and 2.5 mM FU for an additional 30 min. Cells were then fixed and immunostained with antibodies against FU and H3K36me1, -me2, or -me3. Primary antibodies were detected with FITC-conjugated (green) and TR-conjugated (red) secondary antibodies. DNA was stained with DAPI (blue).](pone.0100205.g002){#pone-0100205-g002}

Changes in H3K36 Methylation Status during Porcine Oocyte Maturation and Preimplantation Development of Parthenogenetic Embryos {#s3c}
-------------------------------------------------------------------------------------------------------------------------------

H3K36 methylation status was examined in different stage oocytes using antibodies directed against mono-, di-, or tri-methylated lysines 36 on histone H3 (H3K36me1, -me2, -me3). All three types of methylation on H3K36 were present in germinal vesicle (GV) oocytes, including those with non-surrounded nucleolus (NSN) and surrounded nucleolus (SN), as well as metaphase I (MI) and metaphase II (MII) stage oocytes. The fluorescence intensities of H3K36me1 and -me2 were similar among all oocyte stages ([Figs. 3](#pone-0100205-g003){ref-type="fig"} and [4](#pone-0100205-g004){ref-type="fig"}). In contrast, the fluorescence intensity of H3K36me3 in NSN and SN oocytes was lower than that in MI and MII oocytes ([Fig. 5](#pone-0100205-g005){ref-type="fig"}).

![Changes in H3K36me1 status in porcine oocytes and parthenogenetic embryos.\
(A) Oocytes and parthenogenetic embryos were immunostained with the anti-H3K36me1 antibody, which was then localized with a FITC-conjugated secondary antibody (green). DNA was stained with DAPI (blue). NSN and SN are two types of GV stage oocytes. MI, metaphase I stage oocytes; MII, metaphase II stage oocytes. Scale bar = 20 µm. (B) Relative intensities of fluorescence signals from H3K36me1. Total 13 oocytes and 21 embryos were analyzed in triplicate in this experiment. Bars represent least-squares showed the standard error in each group. P-values \<0.05 were considered statistically significant. There was no significant difference among all groups.](pone.0100205.g003){#pone-0100205-g003}

![Changes in H3K36me2 status in porcine oocytes and parthenogenetic embryos.\
(A) Oocytes and parthenogenetic embryos were immunostained with the anti-H3K36me2 antibody, which was then localized with a FITC-conjugated secondary antibody (green). DNA was stained with DAPI (blue). NSN and SN are two types of GV stage oocytes. MI, metaphase I stage oocytes; MII, metaphase II stage oocytes. Scale bar = 20 µm. (B) Relative intensities of fluorescence signals from H3K36me2. Total 15 oocytes and 22 embryos were analyzed in triplicate in this experiment. Bars represent least-squares showed the standard error in each group. P-values \<0.05 were considered statistically significant. There was no significant difference among all groups.](pone.0100205.g004){#pone-0100205-g004}

![Changes in H3K36me3 status in porcine oocytes and parthenogenetic embryos.\
(A) Oocytes and parthenogenetic embryos were immunostained with the anti-H3K36me3 antibody, which was then localized with a FITC-conjugated secondary antibody (green). DNA was stained with DAPI (blue). NSN and SN are two types of GV stage oocytes. MI, metaphase I stage oocytes; MII, metaphase II stage oocytes. Scale bar = 20 µm. (B) Relative intensities of fluorescence signals from H3K36me3. Total 23 oocytes and 47 embryos were analyzed in triplicate in this experiment. Bars represent least-squares showed the standard error in each group. P-values \<0.05 were considered statistically significant. ^a,b,c^ Values represent least-squares with different superscripts are significantly different (P\<0.05).](pone.0100205.g005){#pone-0100205-g005}

H3K36 methylation status was also examined in parthenogenetic embryos using antibodies against H3K36me1, -me2, or -me3. H3K36me1 and -me2 signals were observed throughout all preimplantation development stages, and showed no change in methylation levels between developmental stages ([Figs. 3](#pone-0100205-g003){ref-type="fig"} and [4](#pone-0100205-g004){ref-type="fig"}). However, H3K36me3 was only present in 2-cell to 8-cell stage embryos ([Fig. 5](#pone-0100205-g005){ref-type="fig"}). H3K36me3 fluorescence signals rapidly decreased after activation and were detected again at the 2-cell stage. H3K36me3 signals increased gradually with the development of the embryo until reaching a peak at the 4-cell stage. H3K36me3 signals decreased to a very low level by the time the embryo reached the 8-cell stage, and became undetectable in morula and blastocyst stage embryos.

H3K36me3 Status in Porcine IVF Embryos {#s3d}
--------------------------------------

To identify the dynamic changes in H3K36 tri-methylation in porcine IVF embryos, we immunostained IVF embryos with antibodies against H3K36me3. The results were similar to those obtained with parthenogenetic embryos. Tri-methylation on H3K36 was decreased soon after fertilization, during which the zygotes underwent demethylation ([Fig. 6](#pone-0100205-g006){ref-type="fig"}). Similar to the pattern found in parthenogenetic embryos, H3K36me3 signals in IVF embryos were detected at the 2-cell stage and reached their highest level at the 4-cell stage. The intensity of H3K36me3 fluorescence signals was very low, and sometimes undetectable, at the 8-cell stage. By the morula and blastocyst stage, H3K36me3 signals were completely undetectable.

![Changes in H3K36me3 status in porcine IVF embryos.\
(A) IVF embryos were immunostained with the anti-H3K36me3 antibody, which was then localized with a FITC-conjugated secondary antibody (green). DNA was stained with DAPI (blue). Scale bar = 20 µm. (B) Relative intensities of fluorescence signals from H3K36me3. Total 30 embryos were analyzed in triplicate in this experiment. Bars represent least-squares showed the standard error in each group. P-values \<0.05 were considered statistically significant. ^a,b^ Values represent least-squares with different superscripts are significantly different (P\<0.05).](pone.0100205.g006){#pone-0100205-g006}

Aberrant H3K36 Tri-methylation in SCNT Embryos {#s3e}
----------------------------------------------

As shown in [Figure 1](#pone-0100205-g001){ref-type="fig"}, H3K36me3 was present in porcine fetal fibroblasts. However, the level of H3K36me3 was low, and even absent, in sperm ([Fig. 7A](#pone-0100205-g007){ref-type="fig"}). On the basis of this difference in tri-methylation status between somatic cells and sperm, we investigated whether H3K36 tri-methylation was aberrant in SCNT embryos compared with IVF embryos. Immunostaining of sperm and IVF and SCNT embryos with an antibody against H3K36me3 revealed a very weak or absent H3K36me3 fluorescence signal in sperm ([Fig. 7A](#pone-0100205-g007){ref-type="fig"}). The same result was also obtained from sperm which was cocultured with oocyte for 1 h in mTBM medium. Culturing of IVF embryos in PZM-3 medium for 18 h resulted in the formation of two pronuclei. H3K36me3 was present at levels that were very low or undetectable by immunostaining in the two pronuclei ([Fig. 7A](#pone-0100205-g007){ref-type="fig"}). However, injection of a single fetal fibroblast cell into the perivitelline space of a denucleated oocyte without activation (Embedded) led to the development of a strong H3K36me3 signal in the cell ([Fig. 7B](#pone-0100205-g007){ref-type="fig"}). Activation of the restructured embryo with an electric pulse followed by culturing for 1 to 18 h in PZM-3 medium resulted in a gradual decrease in the H3K36me3 signal; however, H3K36me3 could still be clearly detected in the pronucleus. H3K36me3 steadily decreased until the 2-cell stage and then increased at the 4-cell stage; however, the intensities were not significantly different among 1-cell, 2-cell and 4-cell stage ([Fig. 7C](#pone-0100205-g007){ref-type="fig"}). From beyond the 8-cell stage to the blastocyst stage, H3K36me3 could not be detected in the embryos.

![Changes in H3K36me3 status in porcine IVF and SCNT embryos.\
(A) Sperm, MII stage oocytes coincubated with sperm in mTBM medium for 1 h (IVF 1 h), and IVF embryos cultured in PZM-3 medium for 18 h (IVF) were immunostained with the anti-H3K36me3 antibody. (B) A single fetal fibroblast cell injected into the perivitelline space of a denuded oocyte without activation (Embedded), a nuclear-transferred embryo cultured in PZM-3 for 1 h post activation (1h), a nuclear-transferred embryo cultured in PZM-3 for 18 h after activation (18h), and other stages of SCNT embryos were immunostained with the anti-H3K36me3 antibody. The antibody was localized with a FITC-conjugated secondary antibody (green). DNA was stained with DAPI (blue). The arrowhead indicates sperm and the arrow indicates the nuclei of donor cell. Scale bar = 20 µm. (C) Relative intensities of fluorescence signals from H3K36me3. Total 41 embryos were analyzed in triplicate in this experiment. Bars represent least-squares showed the standard error in each group. P-values \<0.05 were considered statistically significant. ^a,b,c^ Values represent least-squares with different superscripts are significantly different (P\<0.05).](pone.0100205.g007){#pone-0100205-g007}

Discussion {#s4}
==========

Histone H3K36 methylation has been extensively studied in yeast [@pone.0100205-Pokholok1] and Drosophila [@pone.0100205-Stabell1], [@pone.0100205-Bell1], where it is associated with transcription elongation. In yeast, H3K36 methylation is mediated by Set2 (histone lysine methyltransferase), which has been found to be associated with the elongation-competent form of RNA polymerase II [@pone.0100205-Gerber1], [@pone.0100205-Krogan1]. Transcription is a three-stage process consisting of initiation, elongation and termination; each stage requires a specific set of regulatory factors [@pone.0100205-Venkatesh2], [@pone.0100205-Sims2]. During the elongation process, Set2, which has been found to catalyze the transfer of multiple methyl groups onto the H3K36 residue, is recruited to RNA polymerase II. This suggests that H3K36 methylation has a role in transcription elongation [@pone.0100205-Morris1]. Morris et al. have demonstrated that H3K36 methylation is associated with the transcription-elongation process, showing that this modification is highly enriched over the transcribed regions of several active genes in *Schizosaccharomyces pombe* [@pone.0100205-Morris1]. However, the association of histone H3K36 methylation with transcriptional activity in porcine somatic cells has not been reported.

In the current study, we report the first investigation of histone H3K36 methylation status and its association with transcriptional activity in porcine fetal fibroblasts. Using an immunocytochemical approach, we detected all three types of H3K36 methylations (me1, me2, and me3) in interphase cells. In a recent study, Li et al. also reported formation of H3K36me3 foci in interphase human HeLa cells [@pone.0100205-Li4]. This report and our data collectively suggest that this epigenetic modification (H3K36me3) may be conserved between pigs and humans. Using incorporation of FU into nascent RNA to identify transcriptionally active sites, dot-like structures were seen in nucleoplasm ([Fig. 1](#pone-0100205-g001){ref-type="fig"}), which are specific to Pol II activity [@pone.0100205-Xie1]. Unlike H3K36me1 and -me2, which were distributed uniformly throughout the nucleoplasm, H3K36me3 was distributed within the nucleoplasm as discrete foci, a pattern similar to that displayed by transcriptionally active sites. This similar distribution pattern is consistent with an association of H3K36me3 with transcription. We also provided more direct evidence for this association by analyzing transcriptionally active sites containing FU-labeled nascent RNA. This analysis showed that only H3K36me3 strictly colocalized with transcriptionally active sites ([Fig. 1](#pone-0100205-g001){ref-type="fig"}), suggesting that H3K36me3, but not H3K36me1 or -me2, may be associated with transcription in porcine somatic cells. Luo et al. reported that H3K36me3 colocalized with POLII-Ser2-*P* which is the elongation form of RNA polymerase II in the mouse embryonic stem cells [@pone.0100205-Luo1]. This report also suggests H3K36me3 associates with transcription elongation in mouse embryonic stem cell; this result is similar with our data. To further document the association of H3K36me3 with transcription, we treated porcine fetal fibroblasts with flavopiridol, which inhibits RNA polymerase II-mediated transcription in vitro and in vivo by blocking the transition to productive elongation [@pone.0100205-Chao1], [@pone.0100205-Chao2]. In the presence of flavopiridol, transcriptional activity was inhibited in interphase cells, as evidenced by a lack of FU signal which labeled active transcription sites ([Fig. 2](#pone-0100205-g002){ref-type="fig"}). Notably, H3K36me3 signals were also absent under these conditions, indicating an association of H3K36me3 with transcription elongation. In contrast, nuclear H3K36me1 and -me2 signals still remained, indicating that H3K36me1 and -me2 were not influenced by transcription elongation.

We also examined changes in H3K36 methylation status in porcine oocytes, preimplantation parthenogenetic activation embryos, and IVF embryos. Both H3K36me1 and -me2 were present in GV, MI and MII oocytes, and in all preimplantation stages of parthenogenetically activated embryos. The status of these two types of modification did not change during embryo preimplantation development. This may be because these two modifications have no function in regulating transcription following genome activation in the embryo. H3K36me3 status exhibited a different pattern. Although H3K36me3 was present in GV oocytes, its fluorescence intensity was low. However, H3K36me3 signals subsequently increased, becoming strong in MI and MII stage oocytes ([Fig. 5](#pone-0100205-g005){ref-type="fig"}). In these latter oocytes, the nucleus contained a more condensed chromosome compared with the chromatin in the GV stage oocyte. MI and MII stage oocytes also lack a nuclear membrane, allowing the antibody to more easily access to the chromosome. This may be why MI and MII stage oocytes exhibited a stronger H3K36me3 status than GV stage oocytes ([Fig. 5](#pone-0100205-g005){ref-type="fig"}). In matured oocytes activated by an electric pulse or IVF, H3K36me3 decreased and in some cases disappeared, suggesting the operation of an as yet unknown demethylation mechanism in the nuclei of oocytes during this process. Overexpression of JMJD2A, a histone demethylase of the JMJD2 family, has been shown to reverse tri-methylated H3K9 or H3K36 to di-methylated or unmethylated products in cultured human HeLa cells [@pone.0100205-Whetstine1]. In contrast, RNA interference (RNAi)-mediated depletion of the JMJD2A homolog of *Caenorhabditis elegans* resulted in an increase in H3K9/K36 tri-methylation level in meiotic chromosomes. JMJD2C, another member of the JMJD2 demethylase family, also exhibits demethylation activity toward H3K36me3. Thus, it is possible that the demethylation of H3K36me3 observed in 1-cell stage embryos might be mediated by the JMJD2A or JMJD2C demethylation pathway; although further studies will be required to definitively establishing this.

Embryonic gene activation (EGA) is the process by which an embryo begins to transcribe its newly formed genome. EGA is essential for the synthesis of new proteins and subsequent cleavage events. It has been reported that porcine EGA occurs during the 4-cell stage [@pone.0100205-Hyttel1], [@pone.0100205-Bjerregaard1]. In the current study, H3K36me3 signals were present in both parthenogenetically activated and IVF 2-cell stage embryos. Although the fluorescence intensity was not strong, it was nonetheless detectable. The H3K36me3 modification continuously accumulated, reaching its highest level in 4-cell stage embryos ([Figs. 5](#pone-0100205-g005){ref-type="fig"} and [6](#pone-0100205-g006){ref-type="fig"}). These results suggest that tri-methylation of H3K36 starts at the 2-cell stage and enriched at the 4-cell stage, which corresponds well with the time of EGA in the pig. In the mouse, the major embryonic gene activation occurs in 2-cell stage; however, there is a minor embryonic gene activation in the 1-cell stage which has small quantity of transcription [@pone.0100205-Bellier1]. Similarly, tri-methylation of H3K36 starts in porcine 2-cell stage embryos may be related with the minor embryonic gene activation by the observation that small quantities of transcripts were produced in the 2-cell stage (our unpublished data). During the EGA process, the porcine 4-cell stage embryo starts transcribing its newly formed genome. Accordingly, these results suggest that H3K36me3 might be related to EGA and transcription during the preimplantation development of the porcine embryo. This result is similar to the recent study that showed the emergence of H3K36me3 at the time of zygotic-to-embryonic transition in zebra fish [@pone.0100205-Vastenhouw1]. During transcription elongation in yeast, Set2-mediated H3K36 methylation coordinates the recruitment and activation of the Rpd3S complex over the coding region resulting in the maintenance of a hypoacetylated state and the repression of cryptic transcription [@pone.0100205-Venkatesh2]. H3K36 methylation affects transcription elongation via this Set2/Rpd3S pathway. In humans and mice, H3K36 tri-methylation is regulated by SETD2 methyltransferase (also known as KMT3A/SET2 or HYPB), which acts as the ortholog of yeast Set2 [@pone.0100205-Yuan1], [@pone.0100205-Hu1], [@pone.0100205-Edmunds1]. Human H3K36 methylation is mediated by SETD2, which associates with hyperphosphorylated RNA polymerase II and may play an important role in transcriptional regulation [@pone.0100205-Sun1]. In our study, tri-methylation of H3K36 began in the 2-cell stage embryo; SETD2, or a similar methyltransferase, may be gradually recruited to RNA polymerase II and thereby regulate H3K36me3 modifications at that stage which may contain minor EGA. Subsequently, tri-methylation of H3K36 mediated by SETD2 (or a similar methyltransferase) peaked in 4-cell stage embryos and major EGA started. Additional studies will be required to establish the identity of the methyltransferase that coordinates porcine H3K36 tri-methylation and the regulatory mechanisms underlying it.

After the 8-cell stage and continuing to the blastocyst stage, H3K36me3 was no longer present in embryos. This may be because, after genome activation and formation of the new embryonic genome, H3K36me3 might not be necessary for transcription after the 8-cell stage. Alternatively, some other mechanism may release the tri-methylation of H3K36 and recruit other factors that regulate the transcription and development of the embryo. It has been shown that H3K36me3 is related to paused polymerase and Super Elongation Complex especially in developmentally regulated genes [@pone.0100205-Lin1]. One can speculate that the rise of H3K36me3 at 4-cell stage is a response to an extensive polymerase pause release that promotes EGA and that does not happen again until blastocyst. However, Bošković et al. reported that, in mouse, H3K36me3 was only present in maternal chromatin immediately after fertilization and was absent in other stages of embryos, but was absent in all stages of bovine preimplantation embryos after fertilization [@pone.0100205-Bokovi1]. These observations contrast with our results, possibly because of differences in the antibodies used. In preliminary experiments, we tested different H3K36me3 antibodies from different vendors and were able to obtain a signal using only the one reported here. We also increased the intensity of the permeabilization step of the immunofluorescence staining protocol, which could have improved the ability of the antibody to access embryonic nuclei.

An important factor underlying the low efficiency of SCNT is the incomplete reprogramming of donor cell nuclei. In SCNT, the nucleus of the donor cell carries its own epigenetic structures, which are different from those of gametes [@pone.0100205-Breton1]. After nuclear transfer, abnormal epigenetic modifications occur and induce incomplete reprogramming of the donor nucleus. For example, the acetylation of H4K8 and H4K12 in the somatic nucleus after SCNT is incomplete [@pone.0100205-Wang2], and H3K27me3 signals in blastocysts produced by SCNT are different from those of IVF blastocysts [@pone.0100205-Zhang2]. Our data showed that H3K36me3 is present in porcine fetal fibroblasts ([Fig. 1](#pone-0100205-g001){ref-type="fig"}), but is present at a very low level, or is even absent, in sperm ([Fig. 7A](#pone-0100205-g007){ref-type="fig"}). This difference in H3K36me3 status between somatic cells and sperm may lead to aberrant histone methylation in the SCNT embryo. Upon injection of donor porcine fetal fibroblasts into the perivitelline space of denucleated oocytes without electric pulse activation, a strong H3K36me3 signal was observed ([Fig. 7B](#pone-0100205-g007){ref-type="fig"}). After activation and culture for 1 h, H3K36me3 was still present in the restructured embryo. After culturing for 18 h, a pronucleus formed in the restructured embryo. H3K36me3 decreased to some extent; however, it still could be clearly detected. During this stage, IVF embryos underwent demethylation of H3K36me3 ([Fig. 7A](#pone-0100205-g007){ref-type="fig"}), whereas aberrant tri-methylation of H3K36 occurred in SCNT embryos. H3K36me3 could not be demethylated completely during the early 1-cell stage in SCNT embryos. Interestingly, the H3K36me3 signal became weak at the 2-cell stage, indicating that the nucleus of the restructured embryo was gradually demethylated by the denucleated cytoplasm prior to this point. However, there were no significant differences of the intensities of H3K36me3 among 1-cell, 2-cell and 4-cell stage NT embryos ([Fig. 7C](#pone-0100205-g007){ref-type="fig"}); this result indicates the demethylation of H3K36me3 in 1-cell stage of NT embryo could not be sufficient compared with IVF or parthenogenetic embryos. When the embryo reached the 4-cell stage, H3K36me3 signals increased again and then decreased after the 8-cell stage, indicating demethylation. The changes in H3K36me3 status between the 4-cell and blastocyst stages were similar between SCNT and IVF embryo.

Collectively, our data indicate that H3K36me3 is associated with the elongation phase of transcription in porcine fetal fibroblasts. Developmentally regulated H3K36me3, but not -me1 or -me2, may be a histone mark of EGA in the pig. Aberrant H3K36 tri-methylation occurs during the 1-cell stage in porcine SCNT embryos. The mechanisms underlying the interaction of H3K36me3 with transcription elongation and the effects of abnormal H3K36 tri-methylation on the development of SCNT embryos require further investigation.
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